Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Prospective evaluation of acute toxicity and patient reported outcomes in anal cancer and plan optimization

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Measurement of circulating free DNA in squamous cell carcinoma of the anus and relation to risk factors and recurrence

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Deformable image registration uncertainty for inter-fractional dose accumulation of lung cancer proton therapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Measurement of circulating free DNA in squamous cell carcinoma of the anus and relation to risk factors and recurrence

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Outcome following local excision of T1 anal cancers-a systematic review

    Publikation: Bidrag til tidsskriftReviewpeer review

  5. Udredning og behandling af analcancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND AND PURPOSE: Chemoradiotherapy (CRT) is the standard therapy for localized anal cancer (AC), but this treatment is associated with substantial toxicity. However, there is a lack of prospectively collected toxicity and patient reported outcome (PRO) data from larger cohorts. The purpose was to prospectively collect and determine agreement between physician assessed toxicity (CTCAE) and PRO during and after CRT and to compare IMRT, VMAT and proton-based planning in a subgroup of patients.

MATERIAL AND METHODS: Patients, treated with CRT for AC, were included between 2015 and 2017. NCI-CTCAE v.4.0, EORTC QLQ-C30 and CR29 data were collected baseline, mid-therapy, end-of therapy and 2-4 weeks posttherapy. Treatment planning with 5- or 6-fixed field IMRT, 2 and 3 arc VMAT, and 3- and 4-field proton plans were compared.

RESULTS: One-hundred patients were included. Both CTCAE and PROs related to acute toxicity reached a maximum at end of therapy. Incidences of PROs were markedly higher with only slight to fair agreement to CTCAE, (κ 13-37). Comparative planning revealed dosimetric equality of IMRT and VMAT plans, but superiority of proton plans.

CONCLUSIONS: The high incidence of PRO scores and weak agreement to CTCAE suggest that PROs are important tools complementary to CTCAE in evaluating patient symptoms during and after CRT. Proton therapy has the potential to lower radiation doses to most organs at risk.

OriginalsprogEngelsk
TidsskriftRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Vol/bind128
Udgave nummer2
Sider (fra-til)375-379
Antal sider5
ISSN0167-8140
DOI
StatusUdgivet - aug. 2018

ID: 56565148